CORRECTED: HHS abruptly terminates funding for Atlanta biotech’s next-gen vaccine study
The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating funding for an Atlanta biotech’s lead program that’s currently being tested in a mid-stage trial.
The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating funding for an Atlanta biotech’s lead program that’s currently being tested in a mid-stage trial.
